Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 387

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known.

Wilkes, Michael S., Bell, Robert A., Kravitz, Richard L.·2000·Health Affairs

Abstract

PROLOGUE: Anyone who watches television or reads newspapers or magazines in modern-day America cannot help but notice the dramatic upsurge in the number of prescription drug ads. Drug companies spent $905 million on direct-to-consumer (DTC) advertising in the first half of 1999 alone—a 43 percent increase over spending levels a year earlier, according to IMS Health. CBS HealthWatch reports that in 1998, 66 percent of drug consumers in the central United States recalled seeing a particular product advertised in print, and 61 percent of Southern consumers recalled seeing one advertised on TV. The explosion in DTC drug advertising is fueling the trend toward better-informed consumers. Although this trend might appear benign, it is changing the physician/patient relationship. The authors of this study conclude that evidence is accumulating to suggest that clinical quality of care is harmed by DTC advertising. Michael Wilkes is an associate professor of medicine at the University of California, Los Angeles (UCLA), where he is senior chair of the School of Medicine's four-year Doctoring Curriculum. Robert Bell is a professor of communication at UC Davis. He holds a doctoral degree in communications from the University of Texas, Austin. Richard Kravitz is a professor in the Department of Internal Medicine at UC Davis and directs its Center for Health Services Research in Primary Care. He holds a medical degree from UC San Francisco. ABSTRACT: We provide an overview of what is known about the impact of direct-to-consumer (DTC) advertising of prescription drugs. Specifically, we explore the historical trends that led to the industry's increasing use of this form of promotion. Then, using the published literature to date, we review the impact of DTC advertising on the consumer, the medical profession, and the health care system. We conclude by offering policy suggestions for how the pharmaceutical industry can promote its products more responsibly, how the Food and Drug Administration (FDA) can regulate DTC advertising more effectively, and how the medical and public health communities can educate the public about drug therapies more constructively.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1377/hlthaff.19.2.110

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 18 references

Cited by

See all 387

Metadata

Authors
Wilkes, M. S., Bell, R. A., & Kravitz, R. L.
Venue
Health Affairs
Published
2000-03
Volume
19
Issue
2
Pages
110-128
ISSN
  • 0278-2715 (ISSN-L)
  • 1544-5208
OpenAlex
W2095778652
Cited by
387
References
18
FWCI
17.39
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known. https://app.cochat.ai/papers/10.1377/hlthaff.19.2.110
The paper
Wilkes, M. S., Bell, R. A., & Kravitz, R. L. (2000). Direct-To-Consumer Prescription Drug Advertising: Trends, Impact, And Implications: Aiming drug ads at consumers means big business for drug companies, but its effect on clinical care is not yet known. Health Affairs. https://doi.org/10.1377/hlthaff.19.2.110

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.